This Technical Assistance Publication (TAP), updated in 2021, provides guidance for behavioral health service and substance use disorder treatment programs wanting to develop or update a comprehensive, scalable, and flexible disaster plan. It addresses planning needs specific to programs that offer prevention services, outpatient or residential treatment, medically supervised withdrawal, and pharmacotherapy.
Dashboard: Filter Bricks
Main page content
This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
This advisory reviews diabetes and how it relates to mental illness, stress, and substance use disorders. It highlights ways to integrate diabetes care into behavioral health treatment, such as screening and intake, staff education, integrated care, and counseling support.
This manual offers guidance to clinicians on implementing drug testing in their practice. It presents the mechanics of testing and outlines steps for preparing staff.
This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.
This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.